Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. (Q34479150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

1 reference

attention deficit hyperactivity disorder

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

6

C K Conners

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

A Marchetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Magar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

H Lau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E L Murphy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R Findling

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

E Wineburg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

I Carotenuto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T R Einarson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Iskedjian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1904-1921

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

Children who have attentional disorders: diagnosis and evaluation.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Changes in family function and relationships in children who respond to methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Attention deficit disorder: a review of the past 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Behavioral and cognitive subtypes of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Attentional deficits with and without hyperactivity: teacher and peer perceptions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

The prevalence of attention deficit disorders in a rural midwestern community sample of nine-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

The use of methylphenidate in Michigan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Does methylphenidate normalize the classroom performance of children with attention deficit disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Predictive value of placebo methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

Dosage effects and individual responsivity to methylphenidate in attention deficit disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

The ritalin wars continue

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989086-4

7 January 2021

10.1016/S0149-2918(00)89086-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11768842%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference